F-PKE (2)	
    			    			
                UKHGi002-A            
            
        General
Cell Line | 
					|
| hPSCreg name | UKHGi002-A | 
| Cite as: | UKHGi002-A (RRID:CVCL_A1QG) | 
| Alternative name(s) | 
									 
	F-PKE (2)	 
							 | 
						
| Cell line type | Human induced pluripotent stem cell (hiPSC) | 
| Similar lines | 
							 UKHGi002-B (F-PKE (3))  | 
					
| Last update | 26th April 2022 | 
| User feedback | |
Provider | 
					|
| Generator | Institute of Human Genetics Heidelberg (UKHG) | 
External Databases | 
						|
| BioSamples | SAMEA7390806 | 
| Cellosaurus | CVCL_A1QG | 
| Wikidata | Q102115064 | 
							    
							General Information | 
					|
| Publications | |
| * Is the cell line readily obtainable for third parties? | 
                                     No                                                                      | 
                            
Donor Information
General Donor Information | 
					|
| Sex | male | 
Phenotype and Disease related information (Donor) | 
					|
| Diseases | No disease was diagnosed.
																	 | 
					
| Disease associated phenotypes | no phenotypes | 
Donor Relations | 
							|
| Other cell lines of this donor | |
| All cell lines of this donor's relatives | 
																			 
												Has daughter:
										 
																	 | 
							
External Databases (Donor) | 
						|
| BioSamples | SAMEA7390807 | 
Ethics
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes | 
| Was the consent voluntarily given? | Yes | 
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes | 
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | No | 
| Do you (Depositor/Provider) hold the original Donor Consent Form? | No | 
| If you do not hold the Donor Consent Form, do you know who does? | Yes | 
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | pseudonymised | 
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes | 
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No | 
| How may genetic information associated with the cell line be accessed? | Controlled Access | 
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No | 
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes | 
| Name of accrediting authority involved? | Ethic Commission 2 of Heidelberg University, Medical Faculty Mannheim, | 
| Approval number | 2009-350N-MA | 
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? | Yes | 
| Name of accrediting authority involved? | Ethic Commission 2 of Heidelberg University, Medical Faculty Mannheim, | 
| Approval number | 2009-350N-MA | 
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | 
hIPSC Derivation
General | 
						|
| Source cell type | 
										
				
	
	
			 Synonyms 
		
  | 
							
| Source cell origin | 
										
				
	
			 An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages. 
	
			Synonyms 
		
  | 
							
Reprogramming method | 
						|
| Vector type | Non-integrating | 
| Vector | Episomal | 
Vector free reprogramming | 
						|
Other | 
						|
| Derived under xeno-free conditions | 
								 Unknown 							 | 
						
| Derived under GMP? | 
								 Unknown 							 | 
						
| Available as clinical grade? | 
								 Unknown 							 | 
						
Culture Conditions
| Surface coating | Matrigel/Geltrex | 
| Feeder cells | 
															 No 														 | 
						
| Passage method | Mechanically | 
| Medium | 
								mTeSR™ 1		
		
								 | 
						
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | No  | 
					
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No  | 
					
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Yes  | 
					
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles | 
| POU5F1 (OCT-4) | 
											 Yes 						                 | 
																                
						                
							                 | 
						                ||||
| SOX2 | 
											 Yes 						                 | 
																                
						                
Differentiation Potency
Genotyping
Karyotyping (Cell Line) | 
					|
| Has the cell line karyotype been analysed? | 
								 Yes 								
																	
												Normal, 46, XY
											 
																				
																					
																																							 | 
						
Other Genotyping (Cell Line) | 
					|

Login to share your feedback, experiences or results with the research community.